AstraZeneca India profit falls 13 percent at Rs 18.63 crore in Q1

Written by Ruchika Sharma Published On 2020-08-15T09:15:24+05:30 | Updated On 15 Aug 2020 9:15 AM IST

AstraZeneca India profit falls 13 percent at Rs 18.63 crore in Q1

New Delhi: Drug firm AstraZeneca Pharma India on Monday reported a 13.38 per cent decline in its net profit to Rs 18.63 crore for the quarter ended June. The company had posted a net profit of Rs 21.51 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing.

Revenue from operations stood at Rs 193.57 crore for the quarter under consideration. It was Rs 204.56 crore for the same period year ago, it added.

The board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2020-21, the filing said.

astrazenecaastrazeneca newsastrazeneca pharma indiaq1 resultsnet profitfinancial results

Source : PTI

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751